ACE2 and COVID-19: High bicarbonate concentration, metabolic alkalosis, and hypokalemia in COVID-19 patients are assumed to be due to the activation of the renin-angiotensin-aldosterone (RAA) system via the downregulation of angiotensin-converting enzyme 2 (ACE2) by SARS-CoV-2 [4].